Detalhe da pesquisa
1.
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.
Emerg Infect Dis;
28(4): 828-832, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35203111
2.
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
BMC Infect Dis;
21(1): 544, 2021 Jun 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34107889
3.
Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infection.
Front Immunol;
15: 1287504, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38566991
4.
Skin Swabbing for Staphylococcus aureus-Targeting Phages.
Mil Med;
188(3-4): e463-e467, 2023 03 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34179992
5.
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability.
Front Immunol;
14: 1225025, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37711632
6.
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers.
Open Forum Infect Dis;
9(1): ofab575, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35047649
7.
Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.
PLoS One;
17(10): e0276241, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36251675
8.
Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care Workers.
Open Forum Infect Dis;
9(3): ofac030, 2022 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35198647
9.
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.
medRxiv;
2021 Jul 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34230937
10.
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
PLoS One;
16(9): e0256980, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34495988
11.
IMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents.
PLoS One;
15(6): e0233840, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32555601
12.
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection.
Hum Vaccin Immunother;
9(10): 2165-77, 2013 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23899517